Brief: Tenax Therapeutics Announces Clearance Of The Investigational New Drug Application For Imatinib In Pulmonary Arterial Hypertension

Tenax Therapeutics

06/10/2021 13:38

Oct 6 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX THERAPEUTICS ANNOUNCES CLEARANCE OF THE
INVESTIGATIONAL
NEW DRUG APPLICATION FOR IMATINIB IN PULMONARY ARTERIAL
HYPERTENSION (PAH)
    * TENAX THERAPEUTICS INC - ON TRACK TO INITIATE A SINGLE
PHASE 3
IN PAH IN 2Q 2022
    * TENAX THERAPEUTICS INC - ANTICIPATES RESULTS FROM PK STUDY
IN Q4
OF 2021
    * TENAX THERAPEUTICS INC - EXPECTS TO INITIATE A SINGLE
PHASE 3
STUDY IN Q2 OF 2022

Source text for Eikon:  ID:nBw3RG1V5a 
Further company coverage:  TENX.O 

 ((Reuters.Briefs@thomsonreuters.com;))